Cancer Prevention News and Research

RSS

UNC researcher wins major grant to study the role of endoplasmic reticulum in T-cell metabolism

Jessica Thaxton, PhD, MsCR, associate professor in the Department of Cell Biology and Physiology at the UNC School of Medicine and co-leader of the Cancer Cell Biology Research Program at UNC Lineberger Comprehensive Cancer Center, has been awarded a prestigious $700,000 grant from the Mathers Foundation to support research into the role of the endoplasmic reticulum in T-cell metabolism and cancer development.

1 Sep 2026

Protein degrader shows strong activity against treatment-resistant blood cancers

A first-in-class therapy to target MYC, one of the most sought-after and difficult targets in cancer biology, showed promise in hard-to-treat blood cancers, according to a new preclinical study from The University of Texas MD Anderson Cancer Center published in Blood.

24 Aug 2026

Federal and industry sponsors play complementary roles in cancer clinical trials

A comparative study of the cancer clinical trial portfolios supported by federal funding versus industry funding reveals they have distinct, interdependent roles in cancer research.

20 Aug 2026

New studies reveal hidden control hub for MYC-driven cancers

In a rare pair of papers published back-to-back in the journal Genes & Development, research teams led by senior author Anindya Bagchi, PhD, associate professor in the Cancer Genome and Epigenetics Program at Sanford Burnham Prebys Medical Discovery Institute, establish a unified framework that governs one of cancer's most powerful master regulators.

19 Aug 2026

Colorectal tumors may damage nerves before chemotherapy

Researchers at The University of Texas MD Anderson Cancer Center found that, in preclinical models of colorectal cancer, tumors can start damaging peripheral nerves before chemotherapy begins.

19 Aug 2026

Special journal issue highlights precision prevention in cancer epidemiology

Cancer epidemiology is not merely about counting cases; it is a dynamic field that informs screening policies, resource allocation, and clinical trial design.

19 Aug 2026

What a 38-year study suggests about red meat, white meat, and mortality

Lower intake of red and processed meat was associated with small reductions in all-cause, heart disease, cancer, and stroke mortality in a cohort of nearly one million US adults followed for decades. White-meat-only diets showed additional benefits in some subgroups, while vegetarian diets produced few consistent associations and were limited by small participant numbers and a single baseline dietary assessment.

18 Aug 2026

Blocking caspase-1 appears to reduce the risk of developing lung tumors

Every year, lung cancer kills more than 100,000 people in the United States. Smoking is the leading risk factor for lung cancer, but other environmental exposures can also contribute to the disease.

14 Aug 2026

Weizmann study reveals how DNA repair enzymes choose targets

When a wound does not heal properly, it leaves a scar. Similarly, mutations – which are permanent changes to genetic code – are often the result of damaged DNA that has not been properly repaired.

14 Aug 2026

Personalized T-cell therapy eliminates advanced kidney tumor in teenager

Researchers and physicians at the Hopp Children's Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor.

12 Aug 2026

New program receives CDC grant to expand access to breast and cervical cancer screening

The Louisiana Breast and Cervical Health Program (LBCHP), a program of the LSU LCMC Health Cancer Center and housed at the LSU Health New Orleans School of Public Health, has received more than $3 million from the Centers for Disease Control and Prevention to expand access to breast and cervical cancer screening, diagnostic services and patient navigation across Louisiana.

12 Aug 2026

New UH Health initiative targets Texas healthcare workforce shortage

Addressing Texas' growing healthcare workforce shortage and rising demand for care, the University of Houston has launched UH Health, an academic health enterprise designed to integrate education, research and community engagement across the University.

11 Aug 2026

New gene signature predicts immunotherapy success for bone marrow cancers

A team led by researchers from the German Cancer Research Center (DKFZ), the HI-STEM Stem Cell Institute, and Medical Clinic V at Heidelberg University Hospital (UKHD) has characterized T cells in the bone marrow in cases of multiple myeloma and acute myeloid leukemia: A specific group of tumor-reactive T cells can recognize and, in principle, fight cancer cells, but is often not sufficiently activated.

10 Aug 2026

Localized biochemical halo of IL-10 suppresses immune rejection of pancreatic beta cells

A protein known as interleukin 10 (IL-10) is the lynchpin of a new method to protect transplanted cells from host immune system aggression.

6 Aug 2026

Advances in DNA technology are reshaping preventive healthcare

A new review highlights how advances in DNA technology are reshaping the future of healthcare by shifting the focus from treatment to prevention.

6 Aug 2026

Discovery may help develop new treatments for immunosuppressed skin cancer patients

Researchers at The University of Texas MD Anderson Cancer Center have discovered that immunosuppressed patients with non-melanoma skin cancer are not missing the key cancer-fighting immune cells found in immunocompetent patients, but those cells – known as macrophages – have lost the ability to communicate effectively.

5 Aug 2026

Novel drug puts cancer cells under extreme metabolic stress

Cancer cells have a voracious appetite for sugar-using it to fuel their rapid growth. This is why many scientists have tried to develop drugs that block cancer cells' metabolism by cutting off their sugar supply.

5 Aug 2026

Study offers a potential strategy to make nanoparticle-based cancer drugs more effective

A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to reshape the gut microbiome that can enhance the delivery of certain chemotherapies to tumors, offering a potential strategy to make nanoparticle-based cancer drugs more effective.

31 Jul 2026

Rice University chemists develop cheaper way to synthesize drugs

Pharmaceutical drugs often rely on chemical compounds found in the body. Take phosphate, a common compound cells use as a chemical switch.

29 Jul 2026

Study links inherited genetics to cancer susceptibility and progression

Scientists have found the first direct evidence of the powerful role our genetic makeup plays in influencing our risk of cancer, with inherited genes interacting with acquired genetic mutations to shape how tumors evolve.

26 Jul 2026

Cancer Prevention News and Research

UNC researcher wins major grant to study the role of endoplasmic reticulum in T-cell metabolism

Protein degrader shows strong activity against treatment-resistant blood cancers

Federal and industry sponsors play complementary roles in cancer clinical trials

New studies reveal hidden control hub for MYC-driven cancers

Colorectal tumors may damage nerves before chemotherapy

Special journal issue highlights precision prevention in cancer epidemiology

What a 38-year study suggests about red meat, white meat, and mortality

Blocking caspase-1 appears to reduce the risk of developing lung tumors

Weizmann study reveals how DNA repair enzymes choose targets

Personalized T-cell therapy eliminates advanced kidney tumor in teenager

New program receives CDC grant to expand access to breast and cervical cancer screening

New UH Health initiative targets Texas healthcare workforce shortage

New gene signature predicts immunotherapy success for bone marrow cancers

Localized biochemical halo of IL-10 suppresses immune rejection of pancreatic beta cells

Advances in DNA technology are reshaping preventive healthcare

Discovery may help develop new treatments for immunosuppressed skin cancer patients

Novel drug puts cancer cells under extreme metabolic stress

Study offers a potential strategy to make nanoparticle-based cancer drugs more effective

Rice University chemists develop cheaper way to synthesize drugs

Study links inherited genetics to cancer susceptibility and progression

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News